La chaîne d'options affiche les données clés des options sur actions de Profusa à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Profusa..

Profusa (NASDAQ:PFSA) Stock, Chaîne d'Options

Profusa

Profusa Inc is a digital health technology company based in Emeryville, CA, that has developed a real-time, consumer-friendly platform that is designed to measure an individual's biochemistry, be easy to use, be cost-effective, and provide the necessary data to manage chronic disease and health and wellness decisions to improve health outcomes for a large population of potential users. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.

Profusa Inc

Press Releases

Profusa Announces Commercial and Clinical Collaboration with Head of Angiography, Medical University of Graz, Austria

Profusa to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Profusa Adds Head of Vascular Surgery Department at AZ Sint Blasius Hospital, Belgium to Growing Customer Base

Profusa Adopts NVIDIA-Powered Technology to Build AI-Driven Insight Portal for Continuous Biomarker Monitoring

Opinion

Report Highlights Growth in AI Biomarker Monitoring as Industry Giant's GPUs Power Next-Gen Platform

Profusa Adds a Leading French Critical Limb Ischemia Surgeon to Customer Base

Profusa Invests Additional $1 Million in Digital Treasury Assets

Profusa Expands Sales Footprint with New Distributor for Lumee™ Oxygen Platform in Europe

Profusa Completes Manufacturing Build-Out, On Track to Begin Product Shipments and Revenue in Early 2026

Profusa Outlines Potential Path to $250 Million Revenue by 2030, Driven by Sequential Lumee™ Oxygen and Glucose Monitoring Launches

APLD

NBIS

NVDA

PFSA

SOUN

Autonomix Medical

Biomerica

Check-Cap

Envoy Medical, Inc. - Class A Common Stock

Envoy Medical

Co-Diagnostics

Alpha Tau Medical

Ekso Bionics Holdings, Inc. - Common Stock

Ekso Bionics Holdings

Femasys

HeartSciences

SeaStar Medical Holding Corporation - Common Stock

SeaStar Medical Holding

Intelligent Bio Solutions Inc. - Common Stock

Intelligent Bio Solutions

Iridex

Lifeward

Spectral AI

Modular Medical

ENDRA Life Sciences

Neuraxis

enVVeno Medical Corporation - Common Stock

enVVeno Medical

Nexalin Technology

PAVmed

SINTX Technologies

Strata Skin Sciences, Inc. - Common Stock

Strata Skin Sciences

Tenon Medical

Trinity Biotech plc - American Depositary Shares

Trinity Biotech

Beyond Air

Comments

Profusa

Profusa (PFSA) Options

No option chain data available. Please try again later

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL